PX1 Research provides high-purity Dihexa (PNB-0408) synthesized under strict quality controls for qualified academic, institutional, and industrial research facilities. Every lot undergoes rigorous third-party analytical testing to verify sequence identity, chemical purity, and ultra-low endotoxin levels.
PX1 Research provides high-purity Dihexa (PNB-0408) synthesized under strict quality controls for qualified academic, institutional, and industrial research facilities. Every lot undergoes rigorous third-party analytical testing to verify sequence identity, chemical purity, and ultra-low endotoxin levels.
To buy Dihexa peptide for laboratory research, investigators must source from specialized chemical synthesis vendors providing lot-specific analytical documentation. Dihexa (PNB-0408) is an oligopeptide derivative synthesized for in vitro and animal models investigating hepatocyte growth factor (HGF) signaling and synaptogenesis. PX1 Research supplies high-purity Dihexa verified by reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS).
When procurement departments evaluate prospective vendors for research-grade small molecules and peptides, establishing baseline chemical purity, structural identity, and contaminant profiles is essential to maintaining experimental reproducibility. Dihexa is supplied strictly as a lyophilized powder intended for specialized bench research, receptor binding assays, and cell culture studies.
Dihexa is an N-terminal modified hexanoic acid derivative structurally related to angiotensin IV, represented chemically as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. Unlike standard linear peptides, its modified peptidomimetic architecture was designed to increase metabolic stability in biochemical assays while maintaining high affinity for the domain of hepatocyte growth factor (HGF).
In cell-free and cellular models, Dihexa binds directly to HGF with high affinity. Preclinical evidence indicates that this binding facilitates the dimerization of HGF, which subsequently triggers the autophosphorylation of the c-Met receptor tyrosine kinase. The activation of the HGF/c-Met axis recruits downstream intracellular signaling cascades, including the phosphoinositide 3-kinase (PI3K)/Akt and mitogen-activated protein kinase (MAPK)/ERK pathways. Researchers studying growth factor modulation often cross-reference these signaling cascades within our comprehensive research library.
In vitro and animal models investigating neurodevelopmental and neurodegenerative mechanics frequently focus on Dihexa due to its reported potency in driving spinogenesis and dendritic arborization. In primary hippocampal neuron cultures, incubation with sub-nanomolar concentrations of Dihexa has been observed to stimulate the formation of new dendritic spines and functional synaptic connections.
Rodent model studies examining synaptic density suggest that HGF/c-Met activation via Dihexa enhances glutamatergic neurotransmission by increasing post-synaptic density protein-95 (PSD-95) expression and AMPA receptor trafficking. Furthermore, preclinical trial protocols utilizing animal models of cognitive deficit demonstrate that Dihexa administration correlates with restored spatial memory and accelerated neural circuit remodeling. To examine related compounds targeting central nervous system signaling pathways, explore our catalog of all peptides.
Acquiring research-grade compounds requires stringent verification standards to prevent standard impurities—such as truncated peptide sequences, residual coupling reagents, or heavy metals—from confounding experimental outcomes. PX1 Research subjects every batch of Dihexa to exhaustive analytical validation before distribution.
Purity is quantified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) equipped with UV detection. Qualified lots must achieve a chemical purity threshold of ≥98.0%. Electrospray Ionization Mass Spectrometry (ESI-MS) is simultaneously conducted to verify exact molecular weight and confirm the absence of major adducts or synthesis byproducts. A comprehensive Certificate of Analysis (COA) detailing these findings accompanies every shipment.
For cell culture assays, primary neuronal isolations, and in vivo animal models, trace levels of bacterial endotoxins (lipopolysaccharides) can induce systemic inflammatory responses or localized microglial activation, invalidating experimental control groups. PX1 Research implements rigorous Limulus Amebocyte Lysate (LAL) testing protocols on all lots, ensuring endotoxin levels remain below strictly defined laboratory safety limits (<0.01 EU/mg).
All synthesis and downstream purification processes are executed in compliance with ISO 9001 and ISO 17025 accredited facilities located in the United States. Utilizing modern automated solid-phase peptide synthesis (SPPS) equipment and ISO Class 5 cleanroom environment packaging guarantees that researchers receive compounds free from bio-burden and ambient particulate contamination.
Dihexa possesses distinct hydrophobic characteristics due to its N-hexanoic chain and aromatic amino acid residue. Consequently, direct dissolution in standard aqueous buffers like Phosphate-Buffered Saline (PBS) or sterile water may result in incomplete dissolution or aggregation at higher concentrations.
For optimal reconstitution in laboratory setups, researchers typically dissolve the lyophilized powder first in an organic solvent, such as dimethyl sulfoxide (DMSO) or ethanol, to create a concentrated stock solution. Once completely dissolved, this stock can be diluted into working aqueous media (such as cell culture media or balanced salt solutions) while maintaining organic solvent concentrations below thresholds toxic to the specific biological model under evaluation. Additional handling protocols for lipophilic oligopeptides can be found in our deep dive on Dihexa mechanism and HGF/c-Met signaling.
Maintaining chemical integrity over time requires strict adherence to temperature and atmospheric storage requirements. Lyophilized Dihexa powder should be stored at -20°C or -80°C in a desiccated, dark environment upon arrival. Under these conditions, the compound remains stable for extended periods without significant hydrolysis or oxidative degradation.
Once reconstituted into liquid stock solutions, samples should be divided into single-use aliquots to prevent repeated freeze-thaw cycles, which accelerate physical precipitation and molecular breakdown. Reconstituted aliquots stored at -80°C remain stable for several months, while working solutions kept at 4°C should be utilized within a short experimental window depending on the solvent matrix.
When evaluating peptidergic ligands involved in central nervous system research, investigators frequently compare Dihexa to other established compounds studying synaptic plasticity, neuroprotection, and receptor activation. While Dihexa operates primarily as a small-molecule HGF/c-Met agonist, alternative research peptides act through distinct neuropeptide pathways or growth factor systems.
For example, Semax is an ACTH-derived heptapeptide widely studied for its ability to modulate Brain-Derived Neurotrophic Factor (BDNF) and tropomyosin receptor kinase B (TrkB) expression. Similarly, Selank, a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin, is evaluated in preclinical systems for its influence on GABAergic neurotransmission and enkephalin degradation. Researchers investigating repair processes in systemic or peripheral tissues may also compare these compounds to BPC-157, a pentadecapeptide involved in angiogenic factor signaling. For a detailed breakdown of comparative CNS research protocols, review our analysis on Semax vs. Selank in cognitive research models.
PX1 Research streamlines the procurement process for university laboratories, biotechnology enterprises, and institutional contract research organizations (CROs). Orders are fulfilled directly from our California and Arizona fulfillment centers, with same-day shipping available for qualifying orders placed Monday through Friday.
For high-throughput screening projects, custom assay development, or large-scale animal studies requiring multi-gram quantities, laboratories can apply for dedicated institutional pricing and dedicated account support through our wholesale program. All shipments include lot-traceable COAs, safety data sheets (SDS), and secondary containment packaging to ensure safe delivery and regulatory compliance.
What is the primary mechanism of action for Dihexa in research settings?
Preclinical models show that Dihexa binds to hepatocyte growth factor (HGF) with high affinity, potentiating HGF-induced c-Met receptor dimerization and downstream intracellular signaling cascades involved in synaptogenesis.
What purity level is guaranteed when I buy Dihexa peptide from PX1 Research?
PX1 Research guarantees a chemical purity of ≥98.0% for all Dihexa lots, verified independently using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and mass spectrometry.
How is Dihexa shipped and what is its shelf life?
Dihexa is shipped in lyophilized powder form at room temperature with temperature-stable packaging. Upon receipt, store the unopened vial at -20°C or -80°C for long-term stability up to 24 months.
Is Dihexa soluble in standard aqueous solutions like PBS or sterile water?
Due to its hydrophobic N-terminal hexanoic group, Dihexa has limited direct solubility in pure water or PBS. It is typically first dissolved in an organic solvent like DMSO before diluting into aqueous assay buffers.
Does PX1 Research provide a Certificate of Analysis (COA) with Dihexa?
Yes. Every shipment includes access to a lot-specific COA documenting HPLC purity chromatograms, mass spectrometry molecular weight confirmation, and LAL endotoxin testing results.
What are the endotoxin limits for PX1 Research Dihexa?
PX1 Research enforces strict endotoxin controls, ensuring all lots test below 0.01 EU/mg via Limulus Amebocyte Lysate (LAL) assays to prevent confounding inflammatory responses in cell or animal models.
Can Dihexa be purchased for human clinical or therapeutic use?
No. Dihexa supplied by PX1 Research is strictly sold as a research chemical intended for in vitro, cell culture, and animal preclinical research. It is not for human or veterinary consumption.
How does Dihexa differ from standard growth factor peptides like BDNF analogs?
Dihexa is a small-molecule peptidomimetic designed to target HGF/c-Met signaling rather than TrkB receptors, providing a distinct chemical structure designed for enhanced enzymatic stability in laboratory assays.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.